Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.
The fair value estimate for Chambal Fertilisers and Chemicals has been trimmed slightly from ₹568 to about ₹559.5, which may catch your eye if you track target prices closely. Analysts describe this as fine tuning that lines up with refreshed assumptions, rather than a major reset of the story around the stock. As you read on, you will see how this updated price target fits into the evolving narrative and what it could mean for how you follow the company from here.
Stay updated as the Fair Value for Chambal Fertilisers and Chemicals shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Chambal Fertilisers and Chemicals.
What Wall Street Has Been Saying
🐂 Bullish Takeaways
-
Recent fair value work that trims the estimate for Chambal Fertilisers and Chemicals only slightly, from ₹568 to about ₹559.5, suggests analysts still see the current assumptions as broadly intact, rather than needing a wholesale rewrite.
-
The modest adjustment points to ongoing confidence in the company's ability to support its valuation under refreshed inputs. This can matter if you are watching how sensitive the thesis is to small swings in key variables.
🐻 Bearish Takeaways
-
The fact that the fair value has been revised down, even if only by a small amount, highlights that analysts are not pushing targets higher at this stage and are instead tightening their models.
-
For investors focused on upside potential, a lower fair value, however minor, may prompt closer attention to execution risks and to whether current pricing already reflects much of the identified opportunities.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!
We've flagged 1 risk for Chambal Fertilisers and Chemicals. See which could impact your investment.
What's in the News
-
Chambal Fertilisers and Chemicals has scheduled a board meeting for February 10, 2026, to consider and approve its standalone unaudited financial results for the quarter ended December 31, 2025.
-
On the same date, the board will review the consolidated unaudited financial results for the nine months ended December 31, 2025, providing a broader view of the company's recent financial period.
-
The outcome of this meeting is expected to provide updated financial information for both the latest quarter and the nine month period. Investors can use this information to refresh their understanding of the company's recent performance.
How This Changes the Fair Value For Chambal Fertilisers and Chemicals
-
Fair value trimmed from ₹568 to about ₹559.5, based on updated modelling inputs.
-
Assumed long term revenue growth adjusted from about 4.28% to about 5.85%.
-
Modelled net profit margin moved from about 7.97% to about 8.28%.
-
Assumed future P/E multiple revised from about 18.74x to about 16.14x.
-
Discount rate in the models moved from 13.12% to about 13.15%.
Never Miss an Update: Follow The Narrative
Narratives link a company's real world story to a financial forecast and fair value, so you can see why certain assumptions sit behind a target price. They are refreshed as new data, risks, and catalysts come through.
Head over to the Simply Wall St Community and follow the Narrative on Chambal Fertilisers and Chemicals to stay up to date on:
-
How Chambal is expanding beyond urea into crop protection, specialty nutrients, biologicals, and seeds, and what that could mean for revenue mix and resilience.
-
The role of government policies, subsidies, and capital efficient projects such as the upcoming Technical Ammonium Nitrate plant in supporting margins and earnings potential.
-
Key risks around heavy dependence on urea, aging plants, natural gas price volatility, and the pace of diversification into new agri input segments.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include CHAMBLFERT.nsei .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
